Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-29Clinical Trial Update: Study of the Efficacy and Safety of Pegnano Plus Barivir (Ribavirin) in Treatment-naïve Patients With Chronic Hepatitis C at KienGiang General Hospital [Phase 4]
Phase 4 study evaluating the efficacy and safety of Pegnano Plus Barivir (Ribavirin) in treatment-naïve patients with Chronic Hepatitis C ha…
-
CLINICAL_TRIALS research · 2025-06-29Clinical Trial Update: Early Detection of HCV in Injection Drug Users
A clinical trial assessing early detection of Hepatitis C virus infection in injection drug users is currently recruiting.
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France [NA]
A clinical trial update on community screening and management of hepatitis B, C, and D among the Mongolian population living in France; the …
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Screening of Patients With Hepatic Fibrosis or Cirrhosis B and C [NA]
Recruitment is ongoing for a study screening patients with hepatic fibrosis or liver cirrhosis, including those due to hepatitis B and hepat…
-
CLINICAL_TRIALS withdrawal · 2025-06-22Clinical Trial Update: Pilot Study Evaluate Efficacy of Grazoprevir + Elbasvir for 12 or 16 Weeks in Liver Transplant Recipients. [Phase 3]
A Phase 3 pilot trial evaluating grazoprevir plus elbasvir for 12 or 16 weeks in liver transplant recipients with hepatitis C has been withd…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-22Clinical Trial Update: Community Versus Facility-based Services to Improve the Screening of Active HCV Infection in Cambodia [NA]
Completed clinical trial comparing community-based versus facility-based services to improve screening for active Hepatitis C infection in C…
-
FDA approval · 2025-06-10FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for MAVYRET (glecaprevir and pibrentasvir) from AbbVie Inc., updating the regulatory status of t…
-
FDA approval · 2025-06-10FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for MAVYRET (glecaprevir and pibrentasvir) submitted by AbbVie.
-
CLINICAL_TRIALS research · 2025-06-10Clinical Trial Update: Insulin Resistance in HCV Infection
The study from University of California, San Francisco is investigating insulin resistance in Hepatitis C infection and is currently active …
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study [Phase 4]
Phase 4 No One Waits study assesses acceptability and feasibility of providing hepatitis C treatment at the point of diagnosis in community …
-
CLINICAL_TRIALS research · 2025-05-23Clinical Trial Update: Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk [NA]
This clinical trial entry describes the Kentucky Outreach Service Kiosk (KyOSK) initiative to reduce HIV, Hepatitis C, and overdose risk amo…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: The HOPE Study: Characterizing Patients With Hepatitis B and C
The HOPE Study is currently recruiting to characterize patients with chronic hepatitis B and chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2025-05-14Clinical Trial Update: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C [Phase 2, Phase 3]
Clinical trial update reports completion of a Phase 2/Phase 3 study evaluating Antaitavir Hasophate capsules in combination with Yiqibuvir t…
-
CLINICAL_TRIALS trial_result · 2025-05-13Clinical Trial Update: Delivering a Multi-disease Screening Tool to Migrant Populations [NA]
This update reports the completion of a trial evaluating a multi-disease screening tool for migrant populations. The study targeted HIV, hep…
-
CLINICAL_TRIALS trial_result · 2025-05-11Clinical Trial Update: Project MATLINK: Development and Evaluation of a Screening, Brief Intervention, & Referral to Treatment (SBIRT) Program for Opioid Dependent Prisoners and Probationers Transitioning to the Community [NA]
This completed clinical trial evaluated a Screening, Brief Intervention, and Referral to Treatment (SBIRT) program for opioid-dependent pris…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: A Setting Focus Overdose Prevention Intervention [NA]
A Johns Hopkins trial on a setting-focused overdose prevention intervention is currently recruiting participants among people with HIV infec…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Proteogenomic Monitoring and Assessment of Liver Transplant Recipients
A clinical trial update announcing ongoing recruitment for a study using proteogenomic monitoring to assess liver transplant recipients, inc…
-
CLINICAL_TRIALS research · 2025-04-30Clinical Trial Update: The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an
Clinical trial update on the epidemic status and development trends of hepatitis C infection in pregnant women in Xi'an, with the study curr…
-
CLINICAL_TRIALS trial_result · 2025-04-24Clinical Trial Update: The DETECT HCV Linkage to Care Trial [NA]
The DETECT HCV Linkage to Care Trial has completed. Sponsor: Denver Health and Hospital Authority; Condition: Hepatitis C.
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: A Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1 Hepatitis C [Phase 1, Phase 2]
An early-phase trial evaluating SC Hanferon in combination with Ribavirin for treatment-naïve Genotype 1 Hepatitis C has completed a Phase 1…
-
CLINICAL_TRIALS trial_result · 2025-04-22Clinical Trial Update: Hepatitis C Treatment in Probation and Parole Office [NA]
A clinical trial evaluating hepatitis C treatment in a probation and parole office setting has completed.
-
CLINICAL_TRIALS research · 2025-04-17Clinical Trial Update: Buprenorphine Integration Research and Community Health [NA]
Clinical trial update on buprenorphine integration research and community health, sponsored by Yale University, investigating opioid use dis…
-
FDA approval · 2025-04-15FDA Approved: MAVYRET — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for MAVYRET (glecaprevir and pibrentasvir) submitted by AbbVie.
-
CLINICAL_TRIALS research · 2025-04-15Clinical Trial Update: Drug-Drug Intercations and Direct Acting Antiviral Agents Against HCV
The study update discusses potential drug-drug interactions with direct-acting antiviral agents for hepatitis C and how concomitant medicati…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: HCV Tappt Adherence Study [NA]
This clinical trial update notes that recruitment is ongoing for the HCV Tappt Adherence Study at the University of Illinois at Chicago, foc…